Mark Hopman

Insider Reports History

Location
Irvine, CA
Signature
/s/ Stephen Feider, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Hopman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Beta Bionics, Inc. Chief Commercial Officer Common Stock 31,215 $641,908 $20.56 05 Sep 2025 Direct
Beta Bionics, Inc. Chief Commercial Officer Employee Stock Option (right to buy) 21,725 05 Sep 2025 Direct

Insider Reports Filed by Mark Hopman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BBNX Beta Bionics, Inc. 04 Sep 2025 8 -$288,421 4 Chief Commercial Officer 08 Sep 2025, 18:15
BBNX Beta Bionics, Inc. 02 Sep 2025 1 -$15,996 4 Chief Commercial Officer 04 Sep 2025, 18:45
BBNX Beta Bionics, Inc. 19 Aug 2025 3 -$185,971 4 Chief Commercial Officer 20 Aug 2025, 21:30
BBNX Beta Bionics, Inc. 02 Jun 2025 3 -$15,529 4 Chief Commercial Officer 04 Jun 2025, 19:30
BBNX Beta Bionics, Inc. 27 Feb 2025 2 $0 4 Chief Commercial Officer 03 Mar 2025, 17:45
BBNX Beta Bionics, Inc. 31 Jan 2025 5 $0 4 Chief Commercial Officer 03 Feb 2025, 20:30
BBNX Beta Bionics, Inc. 29 Jan 2025 1 $0 4 Chief Commercial Officer 31 Jan 2025, 16:31
BBNX Beta Bionics, Inc. 29 Jan 2025 0 $0 3 Chief Commercial Officer 29 Jan 2025, 21:43